Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study
about
Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study
description
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study
@en
Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study
@nl
type
label
Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study
@en
Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study
@nl
prefLabel
Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study
@en
Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study
@nl
P2093
P2860
P1433
P1476
Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study
@en
P2093
Shaomin Lin
Shuai Zhang
Xiaopeng Huang
P2860
P304
P356
10.1097/MD.0000000000012503
P407
P577
2018-09-01T00:00:00Z